SACKS OSTEOPATHY LTDActive

Company number 11089477Private limited companyIncorporated 2017

Key figures

£141,661-6.1%
Net assets 2025/26
+11.0%
Average annual growth 2020/21–2025/26
050 k100 k150 k200 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, SACKS OSTEOPATHY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand136,930165,8774,72642,43239,466
Total assets174,235267,350233,683184,817168,630
Total liabilities26,49973,89740,65824,34119,160
Net assets / total equity148,096184,061182,506150,839141,661
Average number of employees44444

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SACKS OSTEOPATHY LTD

Company

SACKS OSTEOPATHY LTD is a private limited company registered with Companies House under company number 11089477. It was incorporated on 30 Nov 2017. Its status is active. The registered office is in London (NW2). Its nature of business (SIC 2007) is specialists medical practice activities (86220), other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £141,661, down 6.1% on the previous year. Cash at bank and in hand was £39,466. Total assets were £168,630 and total liabilities £19,160. The company had an average of 4 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Dec 2027. The next confirmation statement is due by 11 Nov 2026.